BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Pikkel Josef, Ibrahim Ali, Prober Ariel, Marmor Alon, Assy Nimer. Relationship between Retinal Vascular Caliber and Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)International Journal of Environmental Research and Public Health 2013; 10(8): 3409 doi: 10.3390/ijerph10083409
2
Pulmonary Embolism2016; : 168 doi: 10.1002/9781119039112.ch31
3
Kayleigh L Wood, Michael H Miller, John F Dillon. Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver diseaseBMJ Open Gastroenterology 2015; 2(1): e000019 doi: 10.1136/bmjgast-2014-000019
4
Mario D'Amico, Francesca Pasta, Linda Pasta. Thrombophilic genetic factors PAI-1 4G-4G and MTHFR 677TT as risk factors of alcohol, cryptogenic liver cirrhosis and portal vein thrombosis, in a Caucasian populationGene 2015; 568(1): 85 doi: 10.1016/j.gene.2015.05.034
5
George V. Papatheodoridis, Nikolaos Chrysanthos, Evangelos Cholongitas, Efthymia Pavlou, George Apergis, Dina G. Tiniakos, Evangelia Andrioti, George Theodossiades, Athanasios J. Archimandritis. Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver diseaseJournal of Hepatology 2009; 51(5): 931 doi: 10.1016/j.jhep.2009.06.023
6
Keren Borensztajn, Jan H. Von Der Thüsen, Maikel P. Peppelenbosch, C. Arnold Spek. The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigmJournal of Cellular and Molecular Medicine 2010; 14(1-2): 143 doi: 10.1111/j.1582-4934.2009.00980.x
7
An Verrijken, Sven Francque, Ilse Mertens, Janne Prawitt, Sandrine Caron, Guy Hubens, Eric Van Marck, Bart Staels, Peter Michielsen, Luc Van Gaal. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitisHepatology 2014; 59(1): 121 doi: 10.1002/hep.26510
8
M. A. Edens, F. Kuipers, R. P. Stolk. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markersObesity Reviews 2009; 10(4): 412 doi: 10.1111/j.1467-789X.2009.00594.x
9
M. Knaapen, R.S. Kootte, E.G. Zoetendal, W.M. de Vos, G.M. Dallinga-Thie, M. Levi, E.S. Stroes, M. Nieuwdorp. Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota?Clinical Microbiology and Infection 2013; 19(4): 331 doi: 10.1111/1469-0691.12170
10
W Anthony Lizarraga, Samir Dalia, Steven E Reinert, Fred J Schiffman. Venous thrombosis in patients with chronic liver diseaseBlood Coagulation & Fibrinolysis 2010; 21(5): 431 doi: 10.1097/MBC.0b013e328337b3ba
11
Jonathan G. Stine, Patrick G. Northup. Coagulopathy Before and After Liver TransplantationClinics in Liver Disease 2017; 21(2): 253 doi: 10.1016/j.cld.2016.12.003
12
Xingshun Qi, Weirong Ren, Valerio De Stefano, Daiming Fan. Associations of Coagulation Factor V Leiden and Prothrombin G20210A Mutations With Budd–Chiari Syndrome and Portal Vein Thrombosis: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology 2014; 12(11): 1801 doi: 10.1016/j.cgh.2014.04.026
13
Jonathan G. Stine, Blake A. Niccum, Alex N. Zimmet, Nicolas Intagliata, Stephen H. Caldwell, Curtis K. Argo, Patrick G. Northup. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitisClinical and Translational Gastroenterology 2018; 9(3): e140 doi: 10.1038/s41424-018-0002-y
14
Tarek Saleh, Fadi Matta, Fadi Alali, Paul D. Stein. Venous Thromboembolism with Chronic Liver DiseaseThe American Journal of Medicine 2011; 124(1): 64 doi: 10.1016/j.amjmed.2010.08.014
15
Armando Tripodi, Anna L. Fracanzani, Massimo Primignani, Veena Chantarangkul, Marigrazia Clerici, Pier Mannuccio Mannucci, Flora Peyvandi, Cristina Bertelli, Luca Valenti, Silvia Fargion. Procoagulant imbalance in patients with non-alcoholic fatty liver diseaseJournal of Hepatology 2014; 61(1): 148 doi: 10.1016/j.jhep.2014.03.013
16
Nimer Assy, Agness Djibre, Raymond Farah, Maria Grosovski, Alon Marmor. Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver DiseaseRadiology 2010; 254(2): 393 doi: 10.1148/radiol.09090769
17
Luca Valenti, Elena Canavesi, Enrico Galmozzi, Paola Dongiovanni, Raffaela Rametta, Paolo Maggioni, Marco Maggioni, Anna Ludovica Fracanzani, Silvia Fargion. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver diseaseJournal of Hepatology 2010; 53(5): 927 doi: 10.1016/j.jhep.2010.05.023
18
Marco Matteo Ciccone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Gabriella Ricci, Santa Carbonara, Michele Gesualdo, Fiorella Devito, Annapaola Zito, Francesca Cortese, Pietro Scicchitano. Inflammatory bowel disease, liver diseases and endothelial functionJournal of Cardiovascular Medicine 2015; 16(1): 11 doi: 10.2459/JCM.0000000000000149
19
Maria Assunta Zocco, Enrico Di Stasio, Raimondo De Cristofaro, Marialuisa Novi, Maria Elena Ainora, Francesca Ponziani, Laura Riccardi, Stefano Lancellotti, Angelo Santoliquido, Roberto Flore, Maurizio Pompili, Gian Lodovico Rapaccini, Paolo Tondi, Giovanni Battista Gasbarrini, Raffaele Landolfi, Antonio Gasbarrini. Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis developmentJournal of Hepatology 2009; 51(4): 682 doi: 10.1016/j.jhep.2009.03.013
20
Laura Turco, Filippo Schepis, Erica Villa. The Role of Anticoagulation in Treating Portal HypertensionCurrent Hepatology Reports 2018; 17(3): 200 doi: 10.1007/s11901-018-0406-x
21
Xingshun Qi, Guohong Han, Daiming Fan. Management of portal vein thrombosis in liver cirrhosisNature Reviews Gastroenterology & Hepatology 2014; 11(7): 435 doi: 10.1038/nrgastro.2014.36
22
Dmitri Bezinover, Seyedehsan Navabi, Ming Wang, Zheng Li, Meryl William, Jonathan G. Stine. Hyponatremia Is Protective Against the Development of Portal Vein Thrombosis in Patients Undergoing Liver TransplantTransplantation Proceedings 2019; 51(6): 1880 doi: 10.1016/j.transproceed.2019.05.014
23
Niccolò Bitto, Eleonora Liguori, Vincenzo Mura. Coagulation, Microenvironment and Liver FibrosisCells 2018; 7(8): 85 doi: 10.3390/cells7080085
24
Anna Kotronen, Lotta Joutsi-Korhonen, Ksenia Sevastianova, Robert Bergholm, Antti Hakkarainen, Kirsi H. Pietiläinen, Nina Lundbom, Aila Rissanen, Riitta Lassila, Hannele Yki-Järvinen. Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver diseaseLiver International 2011; 31(2): 176 doi: 10.1111/j.1478-3231.2010.02375.x
25
Jason Yerke, Seth R. Bauer, Stephanie Bass, Heather Torbic, Michael Militello, Erin Roach, Ibrahim Hanouneh, Sarah Welch. Effectiveness of venous thromboembolism prophylaxis in patients with liver diseaseWorld Journal of Hepatology 2019; 11(4): 379-390 doi: 10.4254/wjh.v11.i4.379
26
Patrick G. Northup. Hypercoagulation in Liver DiseaseClinics in Liver Disease 2009; 13(1): 109 doi: 10.1016/j.cld.2008.09.003
27
Dominique Charles Valla. Thrombosis and anticoagulation in liver diseaseHepatology 2008; 47(4): 1384 doi: 10.1002/hep.22192
28
W. Nseir, A. Shalata, A. Marmor, N. Assy. Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery DiseaseDigestive Diseases and Sciences 2011; 56(12): 3439 doi: 10.1007/s10620-011-1767-y
29
Wilma Potze, Mohammad S. Siddiqui, Sherry L. Boyett, Jelle Adelmeijer, Kalyani Daita, Arun J. Sanyal, Ton Lisman. Preserved hemostatic status in patients with non-alcoholic fatty liver diseaseJournal of Hepatology 2016; 65(5): 980 doi: 10.1016/j.jhep.2016.06.001
30
Marwan Ghabril, Saurabh Agarwal, Marco Lacerda, Naga Chalasani, Paul Kwo, A. Joseph Tector. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver TransplantationTransplantation 2016; 100(1): 126 doi: 10.1097/TP.0000000000000785
31
Paola Loria, Amedeo Lonardo, Giovanni Targher. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosisClinical Science 2008; 115(1): 1 doi: 10.1042/CS20070311
32
Alison J. Dawson, Thozhukat Sathyapalan, Jacqueline A. J. Smithson, Rebecca V. Vince, Anne-Marie Coady, Ramzi Ajjan, Eric S. Kilpatrick, Stephen L. Atkin. A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver diseaseClinical Endocrinology 2014; 80(6): 843 doi: 10.1111/cen.12258
33
Jesús Monterrubio Villar, Alberto Córdoba López. Trombosis mesentérica y déficit de proteínas C y S en un paciente con hepatitis C crónica en tratamiento con interferón y ribavirinaGastroenterología y Hepatología 2007; 30(5): 271 doi: 10.1157/13101976